AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2009033 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 0
Study 2009033 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 0
Study 2009033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6882984 — intervention group
Group type: EXPERIMENTAL
Intervention: Real ECT
Number of subjects: 70
Study 6882984 — intervention group
Group type: COMPARATOR
Intervention: Sham ECT
Number of subjects: 70
Study 6882984 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up at 6 months
Number of subjects: 70
Study 6882984 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-resistant patients after real ECT
Number of subjects: 70
Study 30568305 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized neoantigen-targeting vaccines
Number of subjects: 0
Study 30568305 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 0
Study 29457707 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective AMPS
Number of subjects: 14
Study 29457707 — intervention group
Group type: COMPARATOR
Intervention: Placebo AMPS (SHAM)
Number of subjects: 14
Study 29457707 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 14
Study 26387494 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alpha-2b monotherapy
Number of subjects: 126
Study 24465022 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute moderate-intensity endurance exercise
Number of subjects: 59
Study 24465022 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham injection)
Number of subjects: 59
Study 24465022 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 59
Study 22999976 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 104
Study 22999976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 18978495 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose apomorphine (APO)
Number of subjects: 63
Study 18978495 — intervention group
Group type: COMPARATOR
Intervention: Low-dose apomorphine (APO)
Number of subjects: 63
Study 18978495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 18978495 — intervention group
Group type: COMPARATOR
Intervention: Finger tapping
Number of subjects: 63
Study 18978495 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate foot tapping
Number of subjects: 63
Study 17224017 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-tape with relevant information regarding implant insertion
Number of subjects: 98
Study 15383887 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin stimulating factor (rhuESF) with iron pretreatment
Number of subjects: 0
Study 15383887 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 11165971 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (loading dose of 450 mg)
Number of subjects: 0
Study 9612875 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 86
Study 7925227 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified household dietary method
Number of subjects: 712
Study 7925227 — intervention group
Group type: COMPARATOR
Intervention: Individual food weighing method
Number of subjects: 712
Study 2624401 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic laser therapy
Number of subjects: 37
Study 28990118 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG laser
Number of subjects: 33
Study 28990118 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulse Nd:YAG laser
Number of subjects: 33
Study 28990118 — intervention group
Group type: COMPARATOR
Intervention: Both lasers
Number of subjects: 33
Study 28212491 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright sitting position
Number of subjects: 8
Study 28212491 — intervention group
Group type: COMPARATOR
Intervention: Lying down position
Number of subjects: 8
Study 26527790 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib (1,500 mg per day) during chemoradiotherapy and as maintenance monotherapy for 12 months
Number of subjects: 688
Study 26527790 — intervention group
Group type: COMPARATOR
Intervention: Placebo during chemoradiotherapy
Number of subjects: 688
Study 26527790 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 688
Study 26527790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 688
Study 23368904 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suction mouthpiece (CSM)
Number of subjects: 72
Study 23368904 — intervention group
Group type: COMPARATOR
Intervention: Conventional mouthpiece
Number of subjects: 72
Study 21429905 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz DCC frontal TMS
Number of subjects: 78
Study 21429905 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 Hz DCC frontal TMS
Number of subjects: 78
Study 21429905 — intervention group
Group type: COMPARATOR
Intervention: 5 Hz DCC frontal TMS
Number of subjects: 78
Study 21429905 — intervention group
Group type: COMPARATOR
Intervention: 20 Hz DCC frontal TMS
Number of subjects: 78
Study 18652725 — intervention group
Group type: COMPARATOR
Intervention: No gown
Number of subjects: 95
Study 18652725 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard gown
Number of subjects: 95
Study 18652725 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified gown
Number of subjects: 95
Study 17015550 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine, fentanyl, and mivacurium
Number of subjects: 41
Study 17015550 — intervention group
Group type: COMPARATOR
Intervention: Atropine and fentanyl
Number of subjects: 41
Study 15330327 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G‐CSF) 5 microg/kg body weight per day subcutaneously
Number of subjects: 53
Study 15330327 — intervention group
Group type: COMPARATOR
Intervention: Meropenem 1 g every 8 hours
Number of subjects: 53
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.3 mmol/kg body weight, administered as three sequential bolus injections of 0.1 mmol/kg at 10-minute intervals over a 20-minute period)
Number of subjects: 74
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (first injection)
Number of subjects: 74
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (second injection)
Number of subjects: 74
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (third injection)
Number of subjects: 74
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (for patients with one lesion observed after first injection)
Number of subjects: 74
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (for patients with one lesion observed after second injection)
Number of subjects: 74
Study 11747004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (overall assessment)
Number of subjects: 74
Study 9324704 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8098222 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g ground, raw flaxseed/d for 4 weeks
Number of subjects: 0
Study 8098222 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g carbohydrate from flaxseed or 25 g flaxseed mucilage
Number of subjects: 0
Study 8098222 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g flaxseed oil or flour/kg in muffins
Number of subjects: 0
Study 8098222 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 g flaxseed/kg in baked muffins
Number of subjects: 0
Study 2436002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril 30 mg
Number of subjects: 6
Study 2436002 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg
Number of subjects: 6
Study 2436002 — intervention group
Group type: COMPARATOR
Intervention: Captopril 12.5 mg
Number of subjects: 6
Study 2436002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30064396 — intervention group
Group type: EXPERIMENTAL
Intervention: mCIMT combined with AOT
Number of subjects: 42
Study 30064396 — intervention group
Group type: COMPARATOR
Intervention: mCIMT alone (Control)
Number of subjects: 42
Study 26645256 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (bypass surgery)
Number of subjects: 80
Study 26645256 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (nonsurgical)
Number of subjects: 80
Study 23941540 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism
Number of subjects: 5182
Study 23941540 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism
Number of subjects: 5182
Study 23941540 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid participants
Number of subjects: 5182
Study 23941540 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent subclinical thyroid dysfunction
Number of subjects: 5182
Study 23941540 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall thyroid function
Number of subjects: 5182
Study 23766376 — intervention group
Group type: EXPERIMENTAL
Intervention: Test intervention (method of labour induction at term)
Number of subjects: 21
Study 23766376 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 21
Study 21395104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie dietary supplement containing a small amount of carbohydrates and fats
Number of subjects: 0
Study 18713758 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-sensor pacemakers (accelerometer and minute-ventilation)
Number of subjects: 20
Study 18713758 — intervention group
Group type: COMPARATOR
Intervention: Single-sensor pacemakers (only accelerometer sensor activated)
Number of subjects: 20
Study 18713758 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-sensor pacemakers
Number of subjects: 20
Study 16648652 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (strength training)
Number of subjects: 210
Study 16648652 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 210
Study 12728108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet and videotape promoting judicious use of antibiotics
Number of subjects: 499
Study 12728108 — intervention group
Group type: COMPARATOR
Intervention: Brochures about effective injury prevention
Number of subjects: 499
Study 11151262 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 2%
Number of subjects: 25
Study 11151262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8969668 — intervention group
Group type: COMPARATOR
Intervention: Incision and drainage (I & D)
Number of subjects: 45
Study 8969668 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage with concurrent fistulotomy
Number of subjects: 45
Study 1315483 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 32
Study 1315483 — intervention group
Group type: EXPERIMENTAL
Intervention: isradipine
Number of subjects: 32
Study 1315483 — intervention group
Group type: COMPARATOR
Intervention: placebo (during 3-week run-out period)
Number of subjects: 32
Study 1315483 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril and isradipine (combined)
Number of subjects: 32
Study 3931325 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin
Number of subjects: 156
Study 3931325 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa
Number of subjects: 156
Study 31305209 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Physiotherapy (AP)
Number of subjects: 46
Study 31305209 — intervention group
Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 46
Study 29978372 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step nucleic acid amplification (OSNA) for cytokeratin 19 mRNA
Number of subjects: 623
Study 29978372 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms constructed using OSNA parameters
Number of subjects: 623
Study 27285928 — intervention group
Group type: EXPERIMENTAL
Intervention: Arg administration (345 μmol Arg HCl/kg BW, 3 times per day)
Number of subjects: 20
Study 27285928 — intervention group
Group type: EXPERIMENTAL
Intervention: Arg administration
Number of subjects: 20
Study 24500154 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrate (NaNO₃) at a dose of 0.1 mmol · kg⁻¹ · d⁻¹ for 3 days
Number of subjects: 13
Study 24500154 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 13
Study 23304970 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrational appliance (Tooth Masseuse), used for a minimum of 20 minutes per day.
Number of subjects: 66
Study 23304970 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vibrational appliance).
Number of subjects: 66
Study 20479486 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mg of pseudoephedrine (PSE)
Number of subjects: 6
Study 20479486 — intervention group
Group type: COMPARATOR
Intervention: Cornstarch placebo (PLA)
Number of subjects: 6
Study 19079956 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase FSH stimulation
Number of subjects: 18
Study 19079956 — intervention group
Group type: COMPARATOR
Intervention: Follicular phase FSH stimulation
Number of subjects: 18
Study 16510769 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNbeta-1a 22 microg once a week (n = 143)
Number of subjects: 421
Study 16510769 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNbeta-1b 250 microg every other day (n = 158)
Number of subjects: 421
Study 16510769 — intervention group
Group type: COMPARATOR
Intervention: IFNbeta-1b 250 microg every other day (nonrandomized, n = 120)
Number of subjects: 421
Study 11853777 — intervention group
Group type: EXPERIMENTAL
Intervention: Color stimuli at low spatial frequencies (SFs)
Number of subjects: 0
Study 11853777 — intervention group
Group type: EXPERIMENTAL
Intervention: Color stimuli at high spatial frequencies (SFs)
Number of subjects: 0
Study 11853777 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromatic stimuli
Number of subjects: 0
Study 11853777 — intervention group
Group type: EXPERIMENTAL
Intervention: Color stimuli
Number of subjects: 0
Study 11853777 — intervention group
Group type: EXPERIMENTAL
Intervention: Luminance stimuli
Number of subjects: 0
Study 11853777 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall SF discrimination threshold
Number of subjects: 0
Study 10206133 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 12
Study 8644459 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunization with antigens from Taenia crassiceps metacestodes
Number of subjects: 56
Study 8644459 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunization
Number of subjects: 56
Study 8644459 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 56
Study 2171449 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 20
Study 2171449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 360877 — intervention group
Group type: COMPARATOR
Intervention: Halothane anesthesia at 1 atmosphere pressure with 30% O2 in inspired air
Number of subjects: 80
Study 360877 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane anesthesia at 2 to 3 atmospheres (absolute) with 97 to 98% O2 in inspired air
Number of subjects: 80
Study 30683245 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AA) on specific acupoints for neck pain
Number of subjects: 48
Study 30683245 — intervention group
Group type: COMPARATOR
Intervention: Auricular acupressure (AA) on unspecific acupoints
Number of subjects: 48
Study 28409669 — intervention group
Group type: EXPERIMENTAL
Intervention: TLSO
Number of subjects: 36
Study 28409669 — intervention group
Group type: COMPARATOR
Intervention: NO
Number of subjects: 36
Study 25878028 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (50 μg, 100 μg, or 200 μg) plus vilanterol (25 μg)
Number of subjects: 3177
Study 25878028 — intervention group
Group type: COMPARATOR
Intervention: Vilanterol (25 μg)
Number of subjects: 3177
Study 23986961 — intervention group
Group type: EXPERIMENTAL
Intervention: F-PVA tape
Number of subjects: 30
Study 23986961 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanish varnish
Number of subjects: 30
Study 23986961 — intervention group
Group type: EXPERIMENTAL
Intervention: ClinPro XT varnish
Number of subjects: 30
Study 23986961 — intervention group
Group type: COMPARATOR
Intervention: Gelatin (placebo)
Number of subjects: 30
Study 21315835 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon occlusion of the coronary sinus (CS)
Number of subjects: 46
Study 21315835 — intervention group
Group type: COMPARATOR
Intervention: Control group (no balloon occlusion)
Number of subjects: 46
Study 19743979 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre-containing formula (1.5 kcal mL(‐1) with added dietary fibre 1.13 g per 100 mL)
Number of subjects: 25
Study 19743979 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (1.5 kcal mL(‐1) without added dietary fibre)
Number of subjects: 25
Study 17827358 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 56
Study 11053722 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler tissue imaging of mitral annular motion
Number of subjects: 0
Study 11053722 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard echocardiographic parameters
Number of subjects: 0
Study 8858409 — intervention group
Group type: COMPARATOR
Intervention: Glucose (GL)
Number of subjects: 10
Study 8858409 — intervention group
Group type: COMPARATOR
Intervention: Waxy Starch (WS)
Number of subjects: 10
Study 8858409 — intervention group
Group type: COMPARATOR
Intervention: Resistant Starch (RS)
Number of subjects: 10
Study 8858409 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (PL)
Number of subjects: 10
Study 1536379 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine sulfate
Number of subjects: 745
Study 1536379 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 745
Study 6504513 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant saccades
Number of subjects: 20
Study 6504513 — intervention group
Group type: COMPARATOR
Intervention: Random saccades
Number of subjects: 20
Study 6504513 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive adaptability of stimuli
Number of subjects: 20
Study 29687689 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% of 10-12 RM
Number of subjects: 22
Study 29687689 — intervention group
Group type: COMPARATOR
Intervention: 100% of 10-12 RM
Number of subjects: 22
Study 30019984 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐based training (bottom‐up approach)
Number of subjects: 28
Study 30019984 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental Enrichment therapy (top‐down approach)
Number of subjects: 28
Study 30019984 — intervention group
Group type: COMPARATOR
Intervention: Control group (therapeutic intervention without perceptual organisation component)
Number of subjects: 28
Study 27316264 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinhole occlusion
Number of subjects: 90
Study 27316264 — intervention group
Group type: EXPERIMENTAL
Intervention: Presenting visual acuity
Number of subjects: 90
Study 27316264 — intervention group
Group type: COMPARATOR
Intervention: Comparison with adults
Number of subjects: 90
Study 27316264 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye specialist visits
Number of subjects: 90
Study 25007003 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine-XR (mean dose 276 +/- 50 mg/d, range 50-300 mg/d)
Number of subjects: 100
Study 25007003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23103305 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute lorazepam (2 mg orally)
Number of subjects: 27
Study 23103305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 20735783 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg bid for 12 weeks
Number of subjects: 53
Study 20735783 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 18796672 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625-mm collimation
Number of subjects: 78
Study 18796672 — intervention group
Group type: COMPARATOR
Intervention: 1.25-mm collimation
Number of subjects: 78
Study 18796672 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study 16075659 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0
Study 16075659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12379549 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided asthma self‐management
Number of subjects: 193
Study 12379549 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 193
Study 10401349 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain assessment by older adults
Number of subjects: 29
Study 10401349 — intervention group
Group type: COMPARATOR
Intervention: Pain assessment by staff
Number of subjects: 29
Study 10401349 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults in pain without pain relief drugs
Number of subjects: 29
Study 10401349 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults with speech difficulties
Number of subjects: 29
Study 7612903 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Clinical Oncology Programs (CCOP) participation
Number of subjects: 16000
Study 7612903 — intervention group
Group type: EXPERIMENTAL
Intervention: Month of accrual and extent of competition for trial participants
Number of subjects: 16000
Study 2200263 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin
Number of subjects: 17
Study 2200263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31206210 — intervention group
Group type: EXPERIMENTAL
Intervention: mCTAR exercise and traditional dysphagia treatment
Number of subjects: 30
Study 31206210 — intervention group
Group type: COMPARATOR
Intervention: Traditional dysphagia treatment
Number of subjects: 30
Study 30533053 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV treatment regimen from a randomized trial
Number of subjects: 0